Clinical trial
Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of…
NCT00056979 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00056979 |
|---|---|
| Title | Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases |
| Official title | Anti-CD45 (YTH-24 & YTH 54) and ANTI-CD52 (CAMPATH-1H) Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Inherited Metabolic Storage Diseases |
| Intervention type | Drug |
| Interventions | CAMPATH-1H, Anti-CD45, FK506, Fludarabine |
| Enrollment | 2 |
| Start date | Jun 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Mar 27, 2003 |
| Last update posted | Sep 23, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: